These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Developing vaccines to control protozoan parasites in ruminants: dead or alive? Innes EA; Bartley PM; Rocchi M; Benavidas-Silvan J; Burrells A; Hotchkiss E; Chianini F; Canton G; Katzer F Vet Parasitol; 2011 Aug; 180(1-2):155-63. PubMed ID: 21680094 [TBL] [Abstract][Full Text] [Related]
4. Progress and Insights Toward an Effective Placental Malaria Vaccine. Gamain B; Chêne A; Viebig NK; Tuikue Ndam N; Nielsen MA Front Immunol; 2021; 12():634508. PubMed ID: 33717176 [TBL] [Abstract][Full Text] [Related]
5. Immunological control of congenital toxoplasmosis in the murine model. Menzies FM; Henriquez FL; Roberts CW Immunol Lett; 2008 Jan; 115(2):83-9. PubMed ID: 18045699 [TBL] [Abstract][Full Text] [Related]
6. Pregnancy-associated malaria: parasite binding, natural immunity and vaccine development. Gamain B; Smith JD; Viebig NK; Gysin J; Scherf A Int J Parasitol; 2007 Mar; 37(3-4):273-83. PubMed ID: 17224156 [TBL] [Abstract][Full Text] [Related]
7. The host-parasite relationship in bovine neosporosis. Innes EA; Wright S; Bartley P; Maley S; Macaldowie C; Esteban-Redondo I; Buxton D Vet Immunol Immunopathol; 2005 Oct; 108(1-2):29-36. PubMed ID: 16098610 [TBL] [Abstract][Full Text] [Related]
8. Malaria vaccine: a current perspective. Sharma S; Pathak S J Vector Borne Dis; 2008 Mar; 45(1):1-20. PubMed ID: 18399312 [TBL] [Abstract][Full Text] [Related]
10. [Toxoplasma gondii: perspectives for a vaccine]. Gottstein B Schweiz Med Wochenschr Suppl; 1995; 65():89S-95S. PubMed ID: 7716458 [TBL] [Abstract][Full Text] [Related]
11. Immunity, morbidity and immunoepidemiology in parasite infections. Dunne DW; Riley EM Parasite Immunol; 2004; 26(11-12):425-8. PubMed ID: 15771678 [No Abstract] [Full Text] [Related]
12. Malaria in pregnancy: linking immunity and pathogenesis to prevention. Rogerson SJ; Mwapasa V; Meshnick SR Am J Trop Med Hyg; 2007 Dec; 77(6 Suppl):14-22. PubMed ID: 18165470 [TBL] [Abstract][Full Text] [Related]
13. Malaria vaccines: using models of immunity and functional genomics tools to accelerate the development of vaccines against Plasmodium falciparum. Duffy PE; Krzych U; Francis S; Fried M Vaccine; 2005 Mar; 23(17-18):2235-42. PubMed ID: 15755603 [TBL] [Abstract][Full Text] [Related]
14. How does Plasmodium falciparum stick to CSA? Let's see in the crystal. Bentley GA; Gamain B Nat Struct Mol Biol; 2008 Sep; 15(9):895-7. PubMed ID: 18769465 [No Abstract] [Full Text] [Related]
15. Safety and immunogenicity of a soluble native Neospora caninum tachyzoite-extract vaccine formulated with a soy lecithin/β-glucan adjuvant in pregnant cattle. Mansilla FC; Moore DP; Quintana ME; Cardoso N; Hecker YP; Gual I; Czepluch W; Odeón AC; Capozzo AV Vet Immunol Immunopathol; 2015 May; 165(1-2):75-80. PubMed ID: 25851060 [TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of ID1-DBL2X predicts its validity as a vaccine candidate in Colombia and supports at least two independently introduced Plasmodium falciparum populations in the region. Rajwani J; Klinger CM; Arango E; Arroyo MI; Sabbagh A; Maestre A; Dacks JB; Gnidehou S; Yanow SK Infect Genet Evol; 2017 Nov; 55():175-185. PubMed ID: 28893687 [TBL] [Abstract][Full Text] [Related]